Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer.
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Ovarian Cancer|Breast Cancer
Interventions: DRUG: Essiac
Sponsor: Women and Infants Hospital of Rhode Island